Patent · US Active

Method for modulating GPR119 G protein-coupled receptor and selected compounds

US7928230B2 · kind B2 · utility

7Cited by

9References

8Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Dean A. Wacker · Chadds Ford, US
Karen A. Rossi · Newtown, US
Ying Wang · Chengdu, CN

Key dates

Filing date	Jul 16, 2008
Grant date	Apr 19, 2011
Priority date	—
Expiry date	Mar 2, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of modulating the activity of the GPR119 G protein-coupled receptor comprising administering to a mammalian patient in need thereof a therapeutically effective amount of at least one compound of Formula I or Formula IA and, optionally, an additional therapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.